BE763580A - Utilisation de lysolecithines comme adjuvants immunologiques - Google Patents

Utilisation de lysolecithines comme adjuvants immunologiques

Info

Publication number
BE763580A
BE763580A BE763580A BE763580A BE763580A BE 763580 A BE763580 A BE 763580A BE 763580 A BE763580 A BE 763580A BE 763580 A BE763580 A BE 763580A BE 763580 A BE763580 A BE 763580A
Authority
BE
Belgium
Prior art keywords
lysolecithins
immunological adjuvants
immunological
adjuvants
Prior art date
Application number
BE763580A
Other languages
English (en)
French (fr)
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of BE763580A publication Critical patent/BE763580A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE763580A 1970-02-27 1971-02-26 Utilisation de lysolecithines comme adjuvants immunologiques BE763580A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2009343A DE2009343C3 (de) 1970-02-27 1970-02-27 Verwendung von Lysolecithinen als immunologische Adjuvantien

Publications (1)

Publication Number Publication Date
BE763580A true BE763580A (fr) 1971-08-26

Family

ID=5763599

Family Applications (1)

Application Number Title Priority Date Filing Date
BE763580A BE763580A (fr) 1970-02-27 1971-02-26 Utilisation de lysolecithines comme adjuvants immunologiques

Country Status (7)

Country Link
US (1) US3752886A (OSRAM)
BE (1) BE763580A (OSRAM)
DE (1) DE2009343C3 (OSRAM)
FR (1) FR2081547B1 (OSRAM)
GB (1) GB1334138A (OSRAM)
NL (1) NL7102368A (OSRAM)
ZA (1) ZA711242B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
DE2619686C2 (de) * 1976-05-04 1986-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verwendung eines Lysolecithins zur Tumorbehandlung
GB2046092B (en) * 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
US4439199A (en) * 1980-02-19 1984-03-27 Alza Corporation Method for administering immunopotentiator
US4455142A (en) * 1980-07-07 1984-06-19 Alza Corporation Method of coadministering an antigen and an immunopotentiator
US4484923A (en) * 1982-03-25 1984-11-27 Alza Corporation Method for administering immunopotentiator
US4666893A (en) * 1983-02-15 1987-05-19 St. Thomas Institute Methods of inducing resistance to bacterial and viral infections
JPS6045518A (ja) * 1983-08-22 1985-03-12 Takeda Chem Ind Ltd 抗シヨツク剤
US4923854A (en) * 1986-01-22 1990-05-08 The Liposome Company, Inc. Solubilization of hydrophobic materials using lysophospholipid
US5084269A (en) * 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen
IE912535A1 (en) * 1990-07-27 1992-01-29 Res Dev Foundation Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
CA2092731A1 (en) * 1993-03-26 1994-09-27 Yaping Shen Mirror amide cord factors and mirror thioesther cord factors for diagnosis of tuberculosis
WO1996011670A1 (en) * 1994-10-14 1996-04-25 The Liposome Company, Inc. Ether lipid liposomes and their therapeutic use
USRE39042E1 (en) * 1996-02-16 2006-03-28 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US6007839A (en) * 1996-02-16 1999-12-28 The Liposome Company, Inc. Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes
US5942246A (en) * 1996-02-16 1999-08-24 The Liposome Company, Inc. Etherlipid containing multiple lipid liposomes
US5965159A (en) * 1996-02-16 1999-10-12 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US6667053B1 (en) 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US5932242A (en) * 1996-10-15 1999-08-03 The Liposome Company, Inc. Ether lipid-containing pharmaceutical compositions and therapeutic uses thereof

Also Published As

Publication number Publication date
FR2081547B1 (OSRAM) 1974-03-22
FR2081547A1 (OSRAM) 1971-12-03
GB1334138A (en) 1973-10-17
DE2009343B2 (de) 1980-02-28
DE2009343C3 (de) 1980-10-23
US3752886A (en) 1973-08-14
ZA711242B (en) 1971-12-29
DE2009343A1 (de) 1971-09-02
NL7102368A (OSRAM) 1971-08-31

Similar Documents

Publication Publication Date Title
BE763580A (fr) Utilisation de lysolecithines comme adjuvants immunologiques
BE748783A (fr) Utilisation d'alkyl-diphenylamines comme
BE772360A (fr) Plafondelement
CH531658A (de) Freiluftkupplung
SE387009B (sv) Brom-zink-ackumulator
IT941721B (it) Procedimento per la preparazione di componenti acrilici
BE802214A (fr) Utilisation de composes perfludralkyl-phosphores comme agents anti-mousses
CH544857A (de) Decke
AT331468B (de) Decke
BE769655A (fr) Preparation de polyacetylalkylene-diamines
IT943974B (it) Procedimento per la preparazione di copolimero di etilene
BE785268A (fr) Preparation de dispersions hyperbasiques
BE773822A (fr) Bis-aroxazolyl-p-polyphenylenes utilisables comme azureurs
BE759843A (fr) Phosphonitrile-esters utilisables comme ignifugeants
BE773972A (fr) Preparation de la pyrrolidine-one-2
IT972869B (it) Procedimento per la preparazione di perfluoroalchilioduri
IT960605B (it) Procedimento per la preparazione di glicidileteri
SE387693B (sv) Tak
IT1048927B (it) Composizioni di p mentan dioli
BE788704A (fr) Allophanimidates utiles comme herbicides
RO70179A (ro) Procedeu pentru prepararea izoprenului
BE774612R (fr) Systeme
IT968446B (it) Procedimento per la preparazione di alogemuri monoaloacetilici
IT966901B (it) Smorzatore di virazioni torsiona li
BE777572A (fr) Composes bis-triazolyliques utilisables comme